Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $190.44 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $144.83 | 1 | $0 (2019) |
| Novo Nordisk Inc | $22.94 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $22.67 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.94 | 1 | Novo Nordisk Inc ($22.94) |
| 2022 | $22.67 | 1 | Janssen Biotech, Inc. ($22.67) |
| 2019 | $144.83 | 1 | Covidien LP ($144.83) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Diabetes | ||||||
| 11/12/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 07/07/2019 | Covidien LP | — | Food and Beverage | In-kind items and services | $144.83 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,217 | 5,254 | $2.9M | $331,563 |
| 2022 | 16 | 1,019 | 1,745 | $249,358 | $60,670 |
| 2021 | 15 | 937 | 1,612 | $200,821 | $52,034 |
| 2020 | 12 | 680 | 1,174 | $158,558 | $36,359 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2021 | 18 | 18 | $4,392 | $1,160 | 26.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2021 | 76 | 89 | $3,560 | $919.02 | 25.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2021 | 11 | 11 | $3,033 | $883.67 | 29.1% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 41 | 48 | $2,064 | $550.08 | 26.7% |
| 88172 | Evaluation of fine needle aspirate | Office | 2021 | 12 | 12 | $1,500 | $388.08 | 25.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 21 | 33 | $1,386 | $366.96 | 26.5% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2021 | 74 | 86 | $1,376 | $358.55 | 26.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 248 | 468 | $63,772 | $14,815 | 23.2% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2020 | 55 | 82 | $24,873 | $5,913 | 23.8% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 36 | 230 | $21,439 | $5,720 | 26.7% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 76 | 85 | $11,329 | $2,660 | 23.5% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2020 | 18 | 20 | $10,392 | $2,604 | 25.1% |
| 88331 | Pathology examination of tissue during surgery | Facility | 2020 | 13 | 28 | $4,844 | $1,442 | 29.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2020 | 72 | 82 | $3,685 | $818.21 | 22.2% |
| 88360 | Microscopic genetic analysis of tumor | Facility | 2020 | 13 | 18 | $2,629 | $682.96 | 26.0% |
| 88112 | Cell examination of specimen | Facility | 2020 | 29 | 29 | $11,223 | $636.00 | 5.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2020 | 44 | 46 | $2,218 | $512.66 | 23.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2020 | 22 | 29 | $1,242 | $320.33 | 25.8% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2020 | 54 | 57 | $912.00 | $236.11 | 25.9% |
About Dr. Daniel Chung, MD
Dr. Daniel Chung, MD is a Anatomic Pathology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689621120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Chung, MD has received a total of $190.44 in payments from pharmaceutical and medical device companies, with $22.94 received in 2024. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($190.44).
As a Medicare-enrolled provider, Chung has provided services to 4,853 Medicare beneficiaries, totaling 9,785 services with total Medicare billing of $480,625. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Pittsburgh, PA
- Active Since 05/30/2006
- Last Updated 02/11/2020
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1689621120
Products in Payments
- Ozempic (Drug) $22.94
- STELARA (Biological) $22.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Pittsburgh
John Ozolek, Md, MD
Anatomic Pathology — Payments: $765.00
Diana Bell, Md, MD
Anatomic Pathology — Payments: $35.53
Dr. Stacey Miller, Md, MD
Anatomic Pathology — Payments: $34.17
Shweta Patel, D.o, D.O
Anatomic Pathology — Payments: $34.07
Dr. Michael Landau, M.d, M.D
Anatomic Pathology — Payments: $18.12
Dr. Karl Fox, Md, MD
Anatomic Pathology